

Please try another search
By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Monday, January 9th. Please refresh for updates.
Tesla (NASDAQ:TSLA) stock rose 3.5% after the electric car manufacturer signaled longer waiting times for potential buyers of some versions of the Model Y in China, suggesting increased demand after recently announced price cuts.
CinCor Pharma (NASDAQ:CINC) stock rose 133% after AstraZeneca (NASDAQ:AZN) agreed to acquire the U.S. biotech in a deal worth as much as $1.8 billion, as the Anglo-Swedish drugmaker looks to expand its pipeline of treatments for heart and kidney disorders.
Alibaba (NYSE:BABA) ADRs rose 4.9% on news that Ant Group's founder Jack Ma will give up control of the Chinese fintech giant in an overhaul, potentially easing government scrutiny.
Visa (NYSE:V) stock rose 1.2% and Mastercard (NYSE:MA) stock climbed 1.7% after KeyBanc upgraded its stance on the credit card giants, both to ‘overweight’ from ‘sector weight’, expecting them to outperform again in 2023.
Goldman Sachs (NYSE:GS) stock rose 0.3% after Bloomberg reported the investment bank was preparing its biggest round of job cuts since 2009 after over-hiring during the pandemic.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.